164 related articles for article (PubMed ID: 17897063)
1. Drug targets from human pathogenic amoebas: Entamoeba histolytica, Acanthamoeba polyphaga and Naegleria fowleri.
Ondarza RN
Infect Disord Drug Targets; 2007 Sep; 7(3):266-80. PubMed ID: 17897063
[TBL] [Abstract][Full Text] [Related]
2. Drug effects on drug targets: inhibition of enzymes by neuroleptics, antimycotics, antibiotics and other drugs on human pathogenic amoebas and their anti-proliferative effects.
Ondarza RN
Recent Pat Antiinfect Drug Discov; 2007 Nov; 2(3):206-16. PubMed ID: 18221178
[TBL] [Abstract][Full Text] [Related]
3. The effects by neuroleptics, antimycotics and antibiotics on disulfide reducing enzymes from the human pathogens Acanthamoeba polyphaga and Naegleria fowleri.
Ondarza RN; Iturbe A; Hernández E
Exp Parasitol; 2007 Jan; 115(1):41-7. PubMed ID: 16806188
[TBL] [Abstract][Full Text] [Related]
4. Naegleria fowleri: a free-living highly pathogenic amoeba contains trypanothione/trypanothione reductase and glutathione/glutathione reductase systems.
Ondarza RN; Hurtado G; Tamayo E; Iturbe A; Hernández E
Exp Parasitol; 2006 Nov; 114(3):141-6. PubMed ID: 16620809
[TBL] [Abstract][Full Text] [Related]
5. Lectins as virulence factors in
Guzmán-Téllez P; Martínez-Castillo M; Flores-Huerta N; Rosales-Morgan G; Pacheco-Yépez J; la Garza M; Serrano-Luna J; Shibayama M
Future Microbiol; 2020 Jul; 15():919-936. PubMed ID: 32716210
[TBL] [Abstract][Full Text] [Related]
6. Amoebicidal effect of chlorine dioxide gas against pathogenic Naegleria fowleri and Acanthamoeba polyphaga.
Sohn HJ; Park AY; Lee JH; Yun KH; Song KJ; Kim JH; Shin HJ
Parasitol Res; 2024 Apr; 123(4):192. PubMed ID: 38652173
[TBL] [Abstract][Full Text] [Related]
7. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.
Schuster FL; Guglielmo BJ; Visvesvara GS
J Eukaryot Microbiol; 2006; 53(2):121-6. PubMed ID: 16579814
[TBL] [Abstract][Full Text] [Related]
8. Larrea tridentata: A novel source for anti-parasitic agents active against Entamoeba histolytica, Giardia lamblia and Naegleria fowleri.
Bashyal B; Li L; Bains T; Debnath A; LaBarbera DV
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005832. PubMed ID: 28793307
[TBL] [Abstract][Full Text] [Related]
9. Trypanothione reductase from the human parasite Entamoeba histolytica: a new drug target.
Tamayo EM; Iturbe A; Hernández E; Hurtado G; de Lourdes Gutiérrez-X M; Rosales JL; Woolery M; Ondarza RN
Biotechnol Appl Biochem; 2005 Apr; 41(Pt 2):105-15. PubMed ID: 15157186
[TBL] [Abstract][Full Text] [Related]
10. Energy production in Entamoeba histolytica: new perspectives in rational drug design.
Saavedra-Lira E; Pérez-Montfort R
Arch Med Res; 1996; 27(3):257-64. PubMed ID: 8854380
[TBL] [Abstract][Full Text] [Related]
11. Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae.
Rice CA; Colon BL; Chen E; Hull MV; Kyle DE
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008353. PubMed ID: 32970675
[TBL] [Abstract][Full Text] [Related]
12. Waterborne protozoan pathogens.
Marshall MM; Naumovitz D; Ortega Y; Sterling CR
Clin Microbiol Rev; 1997 Jan; 10(1):67-85. PubMed ID: 8993859
[TBL] [Abstract][Full Text] [Related]
13. Antiamoebic activities of flavonoids against pathogenic free-living amoebae, Naegleria fowleri and Acanthamoeba species.
Lê HG; Võ TC; Kang JM; Nguyễn TH; Hwang BS; Oh YT; Na BK
Parasites Hosts Dis; 2023 Nov; 61(4):449-454. PubMed ID: 38043540
[TBL] [Abstract][Full Text] [Related]
14. Entamoeba thiol-based redox metabolism: A potential target for drug development.
Jeelani G; Nozaki T
Mol Biochem Parasitol; 2016; 206(1-2):39-45. PubMed ID: 26775086
[TBL] [Abstract][Full Text] [Related]
15. Amebae and ciliated protozoa as causal agents of waterborne zoonotic disease.
Schuster FL; Visvesvara GS
Vet Parasitol; 2004 Dec; 126(1-2):91-120. PubMed ID: 15567581
[TBL] [Abstract][Full Text] [Related]
16. Entamoeba histolytica: a eukaryote with trypanothione metabolism instead of glutathione metabolism.
Ondarza RN; Iturbe A; Hurtado G; Tamayo E; Ondarza M; Hernandez E
Biotechnol Appl Biochem; 1999 Aug; 30(1):47-52. PubMed ID: 10467118
[TBL] [Abstract][Full Text] [Related]
17. Entamoeba histolytica lacks trypanothione metabolism.
Ariyanayagam MR; Fairlamb AH
Mol Biochem Parasitol; 1999 Sep; 103(1):61-9. PubMed ID: 10514081
[TBL] [Abstract][Full Text] [Related]
18. In vitro antiproliferative effects of neuroleptics, antimycotics and antibiotics on the human pathogens Acanthamoeba polyphaga and Naegleria fowleri.
Ondarza RN; Iturbe A; Hernández E
Arch Med Res; 2006 Aug; 37(6):723-9. PubMed ID: 16824931
[TBL] [Abstract][Full Text] [Related]
19. Target identification and intervention strategies against amebiasis.
Nagaraja S; Ankri S
Drug Resist Updat; 2019 May; 44():1-14. PubMed ID: 31112766
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of Naegleria fowleri from Acanthamoeba species by using monoclonal antibodies and flow cytometry.
Flores BM; Garcia CA; Stamm WE; Torian BE
J Clin Microbiol; 1990 Sep; 28(9):1999-2005. PubMed ID: 2229384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
